Increased serum magnesium lowers risk of intracranial aneurysm: Study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-06-22 11:19 GMT   |   Update On 2021-06-22 11:19 GMT

Higher serum magnesium levels could reduce the risk of intracranial aneurysm and the associated aneurysmal subarachnoid hemorrhage, suggests a study published in the American Academy of Neurology journal. An intracranial aneurysm is a balloon-like bulge of an artery wall in the brain. As it increases in size, it applies pressure on the surrounding structures. Following which it may...

Login or Register to read the full article

Higher serum magnesium levels could reduce the risk of intracranial aneurysm and the associated aneurysmal subarachnoid hemorrhage, suggests a study published in the American Academy of Neurology journal.

An intracranial aneurysm is a balloon-like bulge of an artery wall in the brain. As it increases in size, it applies pressure on the surrounding structures. Following which it may remain stagnant or may even rupture in few cases. Once ruptured, it releases blood into the subarachnoid space surrounding the brain leading to subarachnoid hemorrhage. It is a debilitating condition having severe consequences. Serum magnesium concentrations have been indicated in controlling blood pressure and ensuring the optimum function of the vascular endothelium. However, whether higher serum magnesium levels increase or decrease the risk of intracranial aneurysm and the associated subarachnoid hemorrhage has never been evaluated.

A study was conducted by Larsson S and Gill D to explore the association between serum magnesium concentration and risk of intracranial aneurysm.

The researchers utilized five single-nucleotide polymorphisms linked to the serum magnesium levels from a genome-wide association study in 23,829 participants. Also, they collected genetic association estimates for intracranial aneurysms from a genome-wide association a study conducted on 79,429 people. To get the casual estimates, the inverse-variance weighted method was used for the primary analysis

Findings are as follows:

  • Increased genetically predicted serum magnesium concentration was associated with decreased risk of intracranial aneurysm, i.e. genetically predicted serum magnesium concentrations were inversely associated with the risk of intracranial aneurysm.
  • The odds ratio per 0.1 mmol/L for increment in genetically predicted serum magnesium concentrations were at 0.66 at (95% confidence interval: 0.49-0.91)
  • Similarly, the odds ratio for intracranial aneurysm (unruptured and ruptured combined) were at 0.57 (95% confidence interval: 0.30-1.06)
  • Lastly, the odds ratio for unruptured intracranial aneurysm were at 0.67 (95% confidence interval: 0.48-0.92) for aneurysmal subarachnoid hemorrhage.

"This is the first MR study to identify a potential causal association between serum magnesium concentrations and risk of intracranial aneurysm and aneurysmal subarachnoid hemorrhage.", noted the researchers.

The authors concluded that this study bolsters the evidence that an increase in serum magnesium levels lowers the risk of intracranial aneurysm and aneurysmal subarachnoid hemorrhage. Thus, backing up the increasing evidence associated with the significant role of increased magnesium concentrations for overall good cardiovascular health.

Reference:

A study titled, "Association of Serum Magnesium Levels with Risk of Intracranial Aneurysm: A Mendelian Randomization Study", by Larsson S and Gill D published in the American Academy of Neurology journal.

https://n.neurology.org/content/early/2021/05/20/WNL.0000000000012244



Tags:    
Article Source : American Academy of Neurology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News